NCT01132716View on ClinicalTrials.gov

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Herpes ZosterShinglesGenital Herpes
Interventions
DRUG

Valacyclovir Hydrochloride

1000 mg caplet

Trial Locations (1)

58104

PRACs Institute, Ltd., Fargo

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01132716 - Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions | Biotech Hunter | Biotech Hunter